On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondaySep 28, 2020 11:54 am

NetworkNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) Featured in Equity Research Company Update

VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, was featured in an Equity Research Company Update by Maxim Group LLC. The report, titled “Benzo-Benefits Without the Benzo-Baggage – The Case for PH94B Builds,” highlights potential benefits of VistaGen’s PH94B drug candidate, a nasal spray designed for treatment of adults with social anxiety disorder, as compared to treatment with benzodiazepines. The report reads, “Benzodiazepines (benzos) have been available to treat anxiety since the 1960s, and include well-known products such as Xanax, Ativan, and Klonopin. These drug compounds work…

Continue Reading

MondaySep 28, 2020 11:03 am

NetworkNewsBreaks – Iota Communications Inc. (IOTC) Secures Additional Financing from AIP Asset Management

Iota Communications (OTC: IOTC) ("IotaComm"), a wireless communication and data analytics software company, recently announced that it has closed on additional financing from AIP Asset Management, providing it with approximately $1 million of net cash proceeds. "AIP has been a great financing partner for us over the years with investments in the company totaling $15 million, and we are very pleased that their commitment to provide capital continues as we begin to transition to the next phase of our business," said IotaComm CEO Terrence DeFranco in the press release. "We believe that this financing creates great value for our shareholders…

Continue Reading

MondaySep 28, 2020 10:44 am

NetworkNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Announces Launch of One-Stop Solution – iNsights

iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced the launch of its flagship marketing analysis tool, iNsights, which gives brands in-depth and actionable consumer behavior insights to drive more effective marketing campaigns. According to the update, iNsights is an efficient one-stop solution that tracks and analyzes cross-channel campaigns covering China and overseas markets. "iNsights effectively addresses the difficulties presented to marketers by the shallow insights provided by raw data and selective sampling data analysis, as well as the inconvenience and incomparability of multiple tracking systems for different regions," said…

Continue Reading

MondaySep 28, 2020 10:12 am

NetworkNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Featured in Exclusive Broadcast

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced that it was featured in a broadcast titled, “New Opportunities Abound for Specialty Beverage, Water Companies.” The piece highlights significant M&A potential for smaller specialty brands and reads, “Companies such as The Alkaline Water Company, one of the fastest-growing enhanced water companies in the industry, could be an attractive option. . . . Alkaline88 remains one of the top-selling brands in the value-added water category. According to recent trade data, Alkaline88 reported double-digit growth despite the value…

Continue Reading

FridaySep 25, 2020 2:46 pm

NetworkNewsBreaks – 180 Life Sciences Corp. Advancing Lead Program, Plans Additional Clinical Trials

180 Life Sciences, a clinical-stage biotechnology company, is dedicated to producing solutions designed to battle inflammation when the body’s natural processes go awry. The company’s primary focus is to treat fibrosis and inflammation using anti-TNF therapy, designed to block the activity of TNF, a substance in the body that can cause inflammation and lead to immune-system diseases. The company is advancing on this front as discussed by a recent article that reads, “180 Life Sciences’ lead program is in phase 2b/3 clinical trials and expects to deliver its first results next year. Other clinical trials planned by the company are…

Continue Reading

FridaySep 25, 2020 2:19 pm

NetworkNewsBreaks – SRAX Inc.’s (NASDAQ: SRAX) Sequire Provides Key Insight for Public Company Execs

SRAX (NASDAQ: SRAX), a provider of digital-marketing and consumer data-management technology products, gives public companies an edge with critical data to successfully activate media campaigns, engage shareholders and attract investment. The company’s data analytics platform – Sequire – has proven a key tool for decision makers in the public realm, recently doubling its user base to amass over 1 million active investors and traders. A recent article discussing this quotes SRAX founder and CEO Christopher Miglino, who states, “We are creating a community of public company executives that are taking back their data. For too long these leaders have relied…

Continue Reading

FridaySep 25, 2020 2:08 pm

NetworkNewsBreaks – Cybin Corp. Leverages Two-Pronged Approach to Target Psychedelic, Nutraceutical Sectors

Cybin Corp., a Canada-based life-science company, looks to benefit from its growing footprint in two billion-dollar markets: nutraceuticals and psychedelic drugs. Both sectors are projected to see significant growth in the coming years. The global nutraceutical market was valued at $382.51 billion in 2019 and is expected to grow at an 8.3% compound annual growth rate (“CAGR”) over the next seven years. Meanwhile, the psychedelic drugs market is projected to reach $6.85 billion by 2027. Cybin’s business model is structured around two wholly owned divisions focused on targeting both promising spaces. A recent article discussing this reads, “Cybin is committed…

Continue Reading

FridaySep 25, 2020 1:48 pm

NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Shines Spotlight on Dynamic Platform Capabilities

Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, recently had the opportunity to showcase its growing medical technology accomplishments at multiple virtual investor conferences. Trxade Group CEO Suren Ajjarapu took the company’s message well beyond physical borders to virtual summits in the month of September, providing insight into the dynamic capabilities and expansion of the Trxade Exchange platform. A recent article discussing this reads, “Trxade Group has been building its B2B platform into a B2C-friendly portfolio that helps independent local pharmacies compete with large-scale retail chains through drug pricing transparency and network strength. The platform also assists health…

Continue Reading

FridaySep 25, 2020 1:02 pm

NetworkNewsBreaks – Fitness Trends During Rapidly Changing Landscape and Beyond

A recent analysis report written by LikeFolio Founder Andy Swan discusses increased interest in virtual trainers and working out from home, including a high volume of consumer mentions for Apple (NASDAQ: AAPL), Garmin Ltd. (NASDAQ: GRMN) and Peloton Interactive Inc. (NASDAQ: PTON) products and streaming services. The report reads, “While Apple mentions were spiking on Tuesday during its annual keynote event, LikeFolio recorded high volume for some other names, like Garmin (NASDAQ: GRMN) and Peloton (NASDAQ: PTON). What was going on? Consumers were discussing how Apple Fitness+ and the Apple Watch fit into the rapidly changing fitness landscape. Peloton's CEO…

Continue Reading

FridaySep 25, 2020 12:49 pm

NetworkNewsBreaks – DraftKings Inc. (NASDAQ: DKNG) Featured in Analysis Report

DraftKings (NASDAQ: DKNG), offering a range of products designed to fuel the competitive spirits of sports fans, was featured in a recent analysis report that discussed its move to a publicly traded company and subsequent performance. The report, written by LikeFolio Founder Andy Swan, reads, “DKNG went public in an interesting fashion, via merger deal that allowed it to trade on the Nasdaq Global Select Market in April. Purchase intent mentions for the platform increased 158% in the past 90 days vs. prior year. This company is being propelled by macro tailwinds. Mentions of sports gambling ("betting on sports," "sports…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217